Table 3 |
||||
|
correlation between MTDH expression and the clinicopathologic characteristics of breast cancer patients |
||||
|
Characteristics |
n |
MTDH expression |
||
|
|
||||
|
Low expression |
High expression |
p-value |
||
|
|
||||
|
Age(y) |
||||
|
≤ 50 |
66 |
23 |
43 |
0.042 |
|
> 50 |
96 |
49 |
47 |
|
|
Grade |
||||
|
I&II |
118 |
56 |
62 |
0.206 |
|
III |
44 |
16 |
28 |
|
|
TNM stage |
||||
|
I |
51 |
25 |
26 |
0.607 |
|
II |
72 |
32 |
40 |
|
|
III |
39 |
15 |
24 |
|
|
Tumor size |
||||
|
T≤ 2 cm |
80 |
39 |
41 |
0.276 |
|
T > 2 cm |
82 |
33 |
49 |
|
|
Lymph node metastasis |
||||
|
N0 |
88 |
40 |
48 |
0.778 |
|
N1 |
74 |
32 |
42 |
|
|
Expression of Ki67 |
||||
|
low(≤ 10%) |
35 |
21 |
14 |
0.036 |
|
high(> 10%) |
127 |
51 |
76 |
|
|
Expression of p53 |
||||
|
low |
96 |
53 |
43 |
0.001 |
|
high |
66 |
19 |
47 |
|
|
ER |
||||
|
negative |
66 |
22 |
44 |
0.018 |
|
positive |
96 |
50 |
46 |
|
|
PR |
||||
|
negative |
64 |
25 |
39 |
0.265 |
|
positive |
98 |
47 |
51 |
|
|
ErbB-2 |
||||
|
negative |
130 |
61 |
69 |
0.201 |
|
positive |
32 |
11 |
21 |
|
|
|
||||
|
Su et al. Diagnostic Pathology 2010 5:38 doi:10.1186/1746-1596-5-38 |
||||
